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Chapter 20
Phenomenon of Coronavirus Publication
Race
Vladimir M. Moskovkin, Tatyana V. Saprykina, and Igor V. Boichuk
Abstract In the Chapter, we explain the phenomenon of the coronavirus publication
race, analyse a number of typical bibliometric articles,which are structured according
to the standard principle—presenting ranked lists of publications distributed by coun-
tries, journals and institutions, as well as lists of the most cited articles. Twenty-one
online platforms were identified, on which the largest number of articles on coron-
avirus topicswere published, ofwhich two sampleswere identified as of 15December
2020 (82 articles with the term “COVID-19” in article titles and 63 articles with the
term “Coronavirus” in article titles) articles with over 1,000 citations in Elsevier
journals and over 500 times on other online platforms. These articles were catego-
rized by authors, countries and institutions. The samples of articles were reduced
to a single sample with one hundred and twenty-five articles that did not overlap
in two samples, on the basis of which a detailed analysis of the structures of inter-
national co-authorship with the identification of thirty-one countries, the authors of
which participated in international collaboration on the coronavirus research, was
made. For this analysis, a square symmetric matrix of international co-authorship
was developed. A content analysis of highly cited publications on SARS-CoV-2 was
carried out, revealing overlapping topics, for which the multi-topic factor proposed
by us was calculated.
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Introduction
Currently, there is an exponential growth in publications on the topic of coronavirus,
and the coronavirus publication race itself is a very curious phenomenon. To research
it, we used the advanced search capabilities of Google Scholar, testing the terms
“Coronavirus” and “COVID-19” in it. A strong exponential growth of publications
has always been observed in “inflated” research areas of knowledge (nanoscience,
computer science, genomics, etc.) [1], but here the growth just goes off scale. We
have tested these terms in Google Scholar for the last eight months and obtained
the following data (Table 20.1). The search was carried out in the line “in which
the exact phrase occurs”, and the time interval was limited to 2020, since the term
“coronavirus” itself has been known for a long time. It should be noted that a small
percentage of articles for December 2019 cannot be searched by Google Scholar, so
its minimum search coverage is one year.
We see that in 2020, approximately 260 thousand articles were published in which
the word “Coronavirus” occurs, and about 3,700 articles with a similar Russian-
language term. In the titles of articles, this term was found in both languages,
respectively, in 58,900 and 160 articles (Table 20.1).
The number of responses to the terms “COVID-19”, “SARS-CoV-2”, “2019-
nCoV” was several times less, and we assume that most of these responses were
included in articles corresponding to responses to the query for the term “Coron-
avirus”, since we noticed that in one and the same article the same viral infection is
called differently. Thus, our experiments in Google Scholar have shown that of the
Table 20.1 Growth of scientific publications on the problem of coronavirus
Term Number of publications when
searching throughout the article
Number of publications when
searching by article title
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four names of the infection in question, the name “Coronavirus” is the most popular
in scientific papers.
Let us estimate the approximate share of publications on coronavirus-related
topics from the total global volume of articles for the year. According to the US
National Science Foundation (2018) report, 2,555,959 articles on science and engi-
neering (S&E)were published in 2018. Of this amount, 259,000 coronavirus articles
make up 10%. The calculation is not very correct, since the U.S. NSF counts arti-
cles against the Web of Science database, and Google Scholar counts all articles,
including preprints.
Not only physicians and biologists write on the topic of coronavirus, but also soci-
ologists, philosophers, linguists, psychologists, mathematicians, computer scientists,
engineers and specialists in other fields of knowledge. A burning topic has appeared
and everyone is trying to express themselves on it, but as Stefan Zweig wrote about
this: “The biggest trouble for science is to turn into fashion.”
How do the journals manage to print all this? But people no longer rely on them,
they publish preprints on ArXiv.org, medRxiv, ResearchGate, on other servers and
open access platforms, just to be the first.
Against this background, we see two orders of magnitude fewer articles with the
Russian-language term of the virus in question.
Since a huge cluster of publications on coronavirus topics emerged, many review
articles naturally arose, although research articles are distinguished by large lists of
references aswell. OurAdvanced Search ofGoogle Scholar anywhere in the article in
the line: with exact phrase keyword “coronavirus” in conjunction with the keyword
“review” (entered in the line: with at least of the words”) in the search for 2020
resulted in 228,000 responses.
A visual review of them showed that the number of real publications in which
these words occur simultaneously in their titles does not exceed 400. The following
types of reviews are used: systematic review, rapid review, review and meta-analysis,
narrative review, scoping review.
But we will be more interested in publications in a similar search, where the
keyword “review” is replaced by the keyword “bibliometric analysis”. In this case,
we received 958 responses. We conducted both of the above experiments in Google
Scholar on 01.04.2020. Let us consider some of the most important works from the
last experiment.
It is known that PubMed has been hosting COVID-19—publications on a daily
basis since January 17, 2020, when the number of publications was zero. At the same
time, over 300 articles were posted onApril 18 [1]. In this article, for the period under
consideration, there is a graph of such publications posted on a daily basis, which
in a smoothed form has an exponential form with sufficiently large oscillations. In
a shorter period of time J. Lou et al. [2] from January 2020 to 1 March 2020 found
183 publications on PubMed, which were distributed among the first correspondent
authors from 20 different countries and 80 different journals. Most of them are
published in the Journal of Medical Virology (25). A total of 123 articles published
in China were found, of which 103 in English, and only 18 articles from the USA.
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Growth of publications on COVID topics on a daily and weekly basis is dealt
with, respectively, in the works [4−5], which we found outside the framework of the
above experiment in Google Scholar.
The first study using Dimensions, Scopus, Web of Science (WoS) and the curated
list of LitCovid examined the daily growth of COVID-19-related publications in
citation databases and digital libraries from January 1 to April 7 and found better
coverage (9,435 publications) compared to WoS (718) and Scopus (1568). In the
second study, PubMed grew around 1,000 publications weekly, and the PubMed
Central (1398), medRxiv (989), and SSRN (608) repositories had the best coverage
of COVID-19 open access publications.
In the work of K. Kousha & M. Thewall [1], the Dimensions search tool was
used. Its search engine is similar to Google Scholar, in the sense of indexing docu-
ments using public information from theWeb, but has an Applications Programming
Interface (API) that supports automatic downloading for all query matches [5]. K.
Kousha & M. Thewall [1] made queries on a daily basis from March 21 to April 18
2020 for various spellings of coronavirus infection, the dynamics of publications and
their citation were studied. In addition, for the entire period of time (from December
2019 to March 24 2020), the distribution of publications by subject categories, jour-
nals and their types was carried out. Based on the authors’ three tables, we made a
summary table for such distributions (Table 20.2).
Their tables also indicated publications as of 24 March. It is worth noting that
in the work of Kousha & Thewall [1], one of the tables did not quite correctly
title publications in journals, since in addition to journals, preprint archives were
also examined. Too many publications in this search are due to the fact that all
types of them were searched, including articles, preprints, books, chapters, theses,
monographs, proceedings, and even editorials and commentaries were taken into
account in journal publications.
As you can see from Table 20.2, the total number of publications for the entire
period was 21,392, which is consistent with our data obtained using Google Scholar
as of April 7 2020 (Table 20.1). This is a very important result, as K. Kousha & M.
Thewall [1] noted that “The exact COVID-19 coverage of Google Scholar is difficult
to assess because it is not possible to download large sets of publication records.”
Indeed, Google Scholar allows you to view and download only the first thousand
publications.
An order of magnitude fewer publications for the same period of time were identi-
fied by S.B. Patil [6], since he searched exclusively for articles and preprints, and only
for one name of coronavirus infection—COVID-19. He collected 2,184 publications
from 617 sources (journals and preprint archives), which were distributed across
57 countries and covered 6,389 authors, of which 343 published single-authored
publications. From the author’s three tables, we formed a summary table for the top
ten publications in relation to countries, journals (including preprint archives) and
institutions (Table 20.3).
In Yu, Y., et al. [7] as of 20May 2020 on the subject of COVID-19, 15,805 articles
were identified in the Web of Science (WoS) database, of which 186 were published
in December 2019. Of this number, there were 10,601 research articles (67.1%) and



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































20 Phenomenon of Coronavirus Publication Race 317
1,189 (7.5%)—review articles. 14,609 (92.4%) articles were written in English, 623
(3.9%)—in Chinese. 11,575 (73.2%) articles were OpenAccess, 3,626 (22.9%)were
indexed in the WoS core database. From this article, we have combined data similar
to the article [6] into a pivot table (Table 20.4).
In the same work, Top 100 most cited articles in the field of COVID-19 are
selected. Visualized analysis was performed using the VOSviewer tool.
A fuller coverage of WoS publications was used by S. Al-Zaman [8] (December
2019 to June 2020), who obtained 16,384 COVID-19 related literature items, spread
over 55,352 authors, 2,964 sources, 159 countries, 12,805 organizations, and 221
disciplines. Of the total number of publications, 40.015% falls on articles, from
the USA—25.433%, in English—95.313% (there were observed publications in 19
languages). Most of the articles were published in the British Medical Journal (488)
and by scientists from the University of London (2,259). In December, 793 articles
were published. The author notes that at the time of writing, at least 15 relevant
bibliometric analyzes have been published. As before, using the author’s tabular
data, we compiled a pivot table for three Top 10 positions (Table 20.5).
Similar studies on the Scopus database for the period from 1 December 2019 to 1
April 2020were carried out byH. Dehghanbanadaki et al. [9]. A total of 923 COVID-
19 documents were retrieved, of which 418 were original articles. All received 2,551
citations with an average citation of 2.76 per document. As before, for the three Top
10 positions (countries, journals, institutions) of the three tables of the above authors,
we have compiled a summary in Table 20.6.
Much more Scopus-publications were obtained by S.H. Zyoud & S.W. Al-Jabi
[10] from December 2019 up until June 2020. They found 19,044 publications,
of which 48% (9140) were articles. Total publications included authors from 159
different countries. As before, we presented their data for three Top 10 positions in
Table 20.7.
Similar studies were carried out by Zh.Tao et al. [11] on 9 February 2020 on
Web of Science with search strategy: TI= (coronavirus) AND Language= English.
Unlike previous studies, these authors covered a wider time interval: 2000−2020.
As a result, 9,760 articles were found. As in the previous case, we presented them in
Table 20.8.
From a comparison of Tables 20.3–20.7, we see that the top four countries include
China, USA and UK everywhere, and the top ten countries — in addition to these
countries, are also Germany and Canada. The same 5 countries appear in Table 20.8,
obtained over a wider time interval. From these five tables we also see that the top
ten journals include The Lancet and the Journal of Medical Virology 5 times, BMJ,
JAMA and NEJM 4 times. In Tables 20.3–20.7, Huazhong University of Science and
Technology appeared five times and Wuhan University four times.
Table 20.8, as noted above, was obtained over a wider time interval and not one
of its journals was included in the other 5 tables. At the same time, the first three
Chinese institutions are quite often found in Tables 20.3–20.7.
As we can see from Tables 20.3–20.8, the authors conduct their research in a
typical way, identifying the first tens of countries, journals and institutions, the
same applies to other publications of a bibliometric or scientometric nature. As we





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































20 Phenomenon of Coronavirus Publication Race 323
have noticed, mathematicians act similarly. Using a limited arsenal of well-known
mathematical models of the spread of epidemics, the most popular of which is the
SIR-model, or proposing new models, they make calculations for Wuhan, then for
Northern Italy, then for Spain, etc. This is how not only specialists in mathematical
modeling work on “conveyor belt”, and as we showed above with reference to biblio-
metrics, but also all the others, otherwise, where would so many articles come from
(Table 20.1)?
It should be noted that in the latest experiment in Google Scholar, in which
958 responses were received, not all responses are relevant, that is, in a rela-
tively small percentage of publications, the keywords “coronavirus” and “bib-
liometric analysis” are found in the titles of articles. We observed the same
situation when testing the keywords: “COVID-19” and “bibliometric analysis”
(1,790 responses) on 01.05.2020; “Coronavirus” and “scientometric analysis” (168
responses); “COVID-19” and “scientometric analysis” (285 responses).
Since human coronavirus (HCoVs) was first observed in the 1960s, bibliometric
and scientometric analyses often use more extensive years of literature coverage, for
example, 1968−2020, 1970−2020, 2000−2020 and 2003−2020. The scientometric
databases used here, as shown above, cover most often WoS, Scopus, PubMed,
less often the new Dimensions search tool, and almost never Google Scholar. At
the same time, we have shown above that Dimensions and Google Scholar search
tools give similar results when searching for publications on coronavirus topics. This
circumstance, and most importantly the maximum coverage of publications of this
search engine and the convenience of using it determined its choice in our study.
In the process of a detailed visual review of responses to queries for the terms
“COVID-19” and “Coronavirus” at theAdvanced Search ofGoogle Scholar, we iden-
tified 21 online platforms that produce publications on this topic. These are platforms
for commercial publishers of periodicals, major journals, preprint archives, scien-
tific networks and servers of international and national health organizations. They are
briefly described in Appendix 1. This search with 15-day step (from November 1 to
December 15 2020) revealed documents with these terms. The search was carried out
both throughout the document and by its title. The terms “COVID-19” and “Coron-
avirus” were entered in the line ‘with exact phrase”, the name of the online platform
was entered in the line “Return articles published in”, the time interval was taken in
the interval: 2020−2020.
In these experiments, themost cited articleswith citations above 1,000 forElsevier
journals and with citations above 500 for publications of other online platforms
were carefully visually identified. The results of the experiments are presented in
Table 20.9. It ranked online platforms by the number of documents found as of
November 1 2020 when searching the entire document for the term “COVID-19.”
In general, the dynamics of the growth of documents is positive, but failures in the
work of the Google Scholar search engine occurred in four cases when searching on
platforms: Nature, SAGE, arXiv and National Acad Sciences for publications with
the term “COVID-19”, when a decline was noticed, and then again the growth of
documents (Table 20.9). Google Scholar gives the most reliable data when searching
by the title of the document. Looking at the top ten largest online platforms, we can



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































328 V. M. Moskovkin et al.
see that the strongest growth in publications over a one and a half month interval
occurred for the platform Wiley Online Library and SAGE when searching for the
term “COVID-19”.
Table 20.9 clearly identifies the online platformswith the highest number of highly
cited articles. For both terms, these are the Elsevier, Nature, Springer, Wiley Online
Library and JAMA Network platforms, with the latter platform with a small number
of journals being equal to the Elsevier platform in terms of the number of highly
cited articles.
The generalized quantitative characteristics of the above highly cited articles were
determined on November 1 and December 15 2020, the data for the last moment of
time are given in Table 20.10. From it we see that across all online platforms the
number of highly cited articles varied from1 to 20, the number of authors of these arti-
cles—from 1 up to 51, the number of affiliated countries—from 1 to 11, the number
of affiliated institutions—from 1 to 38, the number of articles with international
co-authorship—from 0 to 6.
The metrics for highly cited articles presented in Table 20.10 are summarized in
Table 20.11.
In this table, platform citations, with the exception of medRxiv, correspond to
the standard citations for Scopus and Web of Science databases depending on the
journals included in those databases. On journal publisher online platforms data on
altmetrics are presented. Articles in the journal Cell and Elsevier journals provide
quantitative data on Shares, Likes&Comments and Tweets as such altmetrics, united
in the Social Media group. Tweets and Likes data is available on medRxiv preprints,
National Acad Sciences uses the term Online Impact for altmetrics, articles inWiley
Online Library andNEJM are tagged “metrics”, which gives data on standard citation
and altemetrics. The rest of the online platforms containing Scopus &WoS journals
show altmetrics, which is a comprehensive indicator. In most cases, “Altmetric”,
“Metrics” include data on tweets, news outlets, Mendeley, blogs, Video uploaders,
Redditors, Wikipedia page, Facebook pages, etc. Therefore, the following approach
was used to systematize the data when reflecting values in the Altmetric indicator
of Table 20.11. It consisted in fixing data on “Altmetric” or “Metrics” if they were
available on the platform, and if they were not available, summarized data on Social
Media was taken.
It is interesting that a number of articles with an average citation rate in our sample
generated a very high level of interest among the general public. Thus, the article
by A. Grifoni et al. (2020) “Targets of T cell responses to SARS-CoV-2 coronavirus
in humans with COVID-19 disease and unexposed individuals” (N 81 in Appendix
2) with low citation rates in Google Scholar (786 citations) and on the publisher’s
platform (355 citations) had such SocialMedia scores on this platform: Shares, Likes
& Comments—21,621 and Tweets—22,182.
Union of sets of high-cited article titles from a search for the terms “COVID-
19” and “Coronavirus” by article title led us to 125 different articles (we united all
the different articles from a set of 82 and 63 articles (Table 20.10)). They are all
numbered in descending order by Google Scholar Citations as of December 15 2020
and are listed in Appendix 2.






























































































































































































































































































































































































































































































































































































































































































































































































20 Phenomenon of Coronavirus Publication Race 331
Table 20.11 Citation metrics of highly cited articles with the terms “COVID-19” and
“Coronavirus” in their titles as of 12.15.2020
Online
platform
Google scholar citations Platform citations Altmetric
Min Max Ave Min Max Ave Min Max Ave
Elsevier
COVID-19 1,081 10,824 2,469 434 5,250 1,199 308 108,614 29,756
Coronavirus 1,049 19,786 4,536 465 9,807 2,188 308 94,214 15,036
Nature
COVID-19 510 1,646 888 222 717 402 233 15,857 3,316
Coronavirus 513 7,893 2,478 250 3,848 1,362 339 6,047 2,146
Springer
COVID-19 515 2,253 1,148 227 940 455 37 1,123 447
Coronavirus 515 1,907 1,048 227 590 408 37 572 267
Wiley Online
Library
COVID-19 501 1,117 718 302 548 412 99 3,597 960
Coronavirus 635 2,297 995 303 1,562 636 99 1,764 809
Oxford
COVID-19 − − − − − −
Coronavirus 570 921 746 211 257 234 187 201 194
medRxiv
COVID-19 − − − − − −
Coronavirus 894 894 894 6,472 6,472 6,472 2,973 2,973 2,973
SAGE
COVID-19 537 829 683 310 348 329 386 386 386




COVID-19 529 621 581 373 621 529 183 1,975 1,332
Coronavirus 529 1,668 1,155 167 736 1,668 183 420 759
JAMA
COVID-19 535 8,012 1,487 0 2,518 512 788 14,445 4,490
Coronavirus 501 11,247 2,467 0 4,772 914 367 11,578 3,498
Cell
COVID-19 518 786 678 282 396 339 393 43,803 10,119
Coronavirus 565 3,685 1,496 300 1,797 728 339 43,803 13,027
(continued)




Google scholar citations Platform citations Altmetric




COVID-19 979 1,226 1,103 662 897 780 708 5,069 2,889
Coronavirus − − − − − − − − −
NEJM
COVID-19 965 965 965 379 379 379 9,717 9,717 9,717
Coronavirus − − − − − − – − −
The characteristics of these numbered articles in the context of the number of
authors, affiliated institutions, member countries and Google Scholar Citations are
given in Appendix 3. From this Appendix, we determine the number of member
countries in the considered highly cited articles; it is equal to 31.
Redistributing these articles by country, we come to Appendix 4. It ranked coun-
tries in descending order of the total number of articles.We see a noticeable leadership
of China in terms of the number of articles and their citation. Based on Appendix
4, we get a more compact table, which clearly shows the distribution of the number
of articles by countries without international co-authorship (89 articles) and with
international co-authorship (36 articles) (Table 20.12).
In this table, we observe the 6 largest international collaborations with the number
of countries greater than or equal to five. Five of them include the USA and China.
Such collaborations, according to Table 20.10, may include more than 30 different
institutions.We cannot estimate the impact of international collaborations on citation
based on Table 20.12 data, since for this you need to know the lifetime of articles.
To study international collaborations, we have developed a symmetric square
matrix of their features (Table 20.13), on the diagonal of which are the numbers
of articles with international participation for each country (they are taken from
Appendix 4), and the plus sign marks the countries with which articles with interna-
tional participation are published. The matrix in the upper zone (11 countries from
China to Saudi Arabia) is sufficiently dense, and in the middle and lower zone it is
sparse. It follows from it that China, the USA and the UK are leading in the number
of articles in international collaborations.
On the basis of the data gathered, the average values of the number of countries of
participants and authors per article were calculated. In the first case, this value was
1.66 (approximately 2 countries), in the second—12.72 (about 13 authors).
Comparing the list of the first ten most cited articles from Appendix 2 with the
data on the ranked lists of such articles from other studies, we showed that in the top
ten articles of works [7, 9, 10] six articles coincided with our list, in the work of K.
Kousha & M. Thelwall [1] and four articles coincided, in the work of S.B. Patil [6]
three articles coincided.
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Table 20.12 Distribution of articles by country with and without international co-authorship as of
15.12.2020















China, Australia 3 3,421
China, USA, UK 2 2,108
China, USA 7 1,191
China, Singapore 1 1,907
USA, Switzerland, Sweden 1 1,753
UK, Netherlands 1 1,656
Switzerland, Greece 1 1,577
China, USA, Germany, Netherlands,
Russia, Spain
1 1,326
China, USA, UK, Australia, Canada,
Denmark, Italy, S.Korea, Netherlands,
Saudi Arabia, UAE
1 1,315
China, UK, Germany, Italy, Oman,
Republic of Congo, Saudi Arabia
1 1,276
China, Canada 1 1,182
China, Japan 1 1,117
USA, UK, Australia, Sweden 1 1,107
Belgium, France, Italy 1 962
China, USA, Netherlands 1 935
USA, UK 1 921
China, Belgium 1 862
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Table 20.12 (continued)
Country Number of articles Average citations google scholar
citations
China, USA, UK, Italy, Japan 1 803
UK, Canada 1 707
UK, Germany, Italy 1 679
China, USA, Italy 1 633
Taiwan, USA 1 606
USA, UK, Austria, Belgium,
Germany, Ireland, Netherlands
1 593
Brazil, Italy, Paraguay 1 537
Brazil, Spain 1 530
Germany, Greece, Romania 1 518
Total 36 1,309
Summary 125 1,782
In conclusion of this study, we conducted a content analysis of our sample of arti-
cles, selecting 31 research topics (Table 20.14). This table shows the article numbers
from Appendix 2 corresponding to these topics. From it we see a large number of
articles covering several topics. To quantify this multi-topic character, you can enter
a multi-topic factor equal to the number of all articles listed in Table 20.14 divided
by 125, it will be equal to: 233/125 = 1.864.
Most often, in the articles under consideration, attention is paid to the geographical
aspect of the study (31 articles), in the secondplace is the clinical picture of the disease
(21 articles), in the third place is the issue of therapy (19 articles).
It is important to note that the analysis and distribution of the 125 most cited
articles according to the criteria of their belonging to a particular field of knowledge
was a very difficult task. The main difficulty is associated with the presence among
these articles not only of those that could conventionally be called “mono-topical”,
but also the articles that can be called “bi-topical” and even “poly-topical”. At the
same time, the prevalence of a particular coronavirus topic in an article is not always
unambiguous, since many articles contain subtopics, as a rule, already stated in
the title of the article, and sufficiently manifest and important to be the basis for
classifying a particular article in two or even several groups at the same time. It goes
without saying that the assignment to a particular group is based not only on the title
of the article or its abstract, but on the entire text. (Although, of course, no one doubts
the correspondence between the content of the article, its abstract and the main text.)
But even this approach, unfortunately, does not guarantee the absolute indisputability
of assigning an article to one or another group (or groups). At the same time, the
determination of the belonging of the overwhelming majority of articles to one or
another of the groups we have singled out seems to us quite substantiated.































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































20 Phenomenon of Coronavirus Publication Race 339
Table 20.14 Quantitative distribution of the 125 most cited articles by research topic
№ Research topic Article numbers Number of articles %
1 Etiology (origin) 6, 27, 55, 70, 89 5 6.25





8, 18, 19, 27, 35, 49, 52, 53,
55, 88, 111
11 8.8
4 Detection, testing, diagnosis,
monitoring
17, 54, 62, 84, 101, 104, 105,
108
8 6.4
5 Risk factors, comorbidity 3, 13, 15, 20, 31, 38, 39, 40,
75, 96, 124
11 8.8
6 Mortality 3, 13, 22, 25, 39, 85, 116 7 5.6
7 Clinical picture 1, 2, 3, 4, 9, 10, 15, 19, 37,
47, 64, 68, 70, 72, 74, 85, 88,
98, 103, 118, 120
21 16.8
8 Therapy 14, 27, 42, 43, 45, 48, 50, 54,
63, 64, 65, 73, 91, 94, 95,
110, 113, 117, 125
19 15.2
9 Comparisons, conclusions 5, 21, 44 3 2.4
10 Complications, damage to
various body systems
24, 26, 30, 41, 57, 79, 86, 90,
118, 123
10 8
11 Virology 7, 35, 44, 53, 55, 69, 118, 121 8 6.4
12 Immunology 10, 64, 66, 81, 83, 87, 97,








32, 58, 59,78, 115 5 4
15 Social aspects 16, 46, 71, 78, 99, 106, 107 7 5.6
16 Reviews 19, 29, 48, 51, 70, 77, 82, 93,
104, 120
10 8
17 Age, gender, racial, family
and ethnic aspects
3, 8, 43, 45, 77, 92, 100, 103,
125
9 7.2
18 Pharmaceuticals 12, 14, 43, 48, 50, 73, 95,
110, 116, 117
10 8
19 Vaccination 121 1 0.8
20 Epidemiology 4,7,16, 21, 23, 29, 34, 36, 46,
85, 106, 118
12 9.6
21 Laboratory data 28, 103, 112 3 2.4
22 Periodization 61 1 0.8
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Table 20.14 (continued)
№ Research topic Article numbers Number of articles %
23 Geographic aspect 2, 5, 11,13, 15, 22, 24, 25, 34,
36, 39, 46, 47, 53, 61, 63, 69,
72, 74, 82, 88, 93, 99, 100,
101, 102, 106, 112, 116, 123,
125
31 24.8
24 Cellular level 30, 75, 81, 87, 114, 119, 121 7 5.6
25 Control measures and
prevention
4, 60, 70, 71 85 5 4
26 Statistical data 61 1 0.8
27 Forecasting 15, 20, 22, 63, 104, 113, 6 4.8
28 Case reports 118, 122 2 1.6




31 Impact on the branches of
medicine
76 1 0.8
As for singling out the relevant groups, its criteria are a synthesis of the content
analysis of the articles in question and similar groups that exist on some platforms,
for example, ResearchGate. We are aware that the boundaries between some of the
groups we propose may seem elusive. Thus, for example, a case report is hardly
possible without describing the clinical picture, and the “cellular level” is relevant
for many other groups identified by us.
Conclusions
In this chapter, we endeavored to explain the phenomenon of the coronavirus publi-
cation race, analyzed a number of typical bibliometric articles, which are struc-
tured according to the standard principle—presenting ranked lists of publications
distributed by countries, journals and institutions, as well as lists of the most cited
articles. With this analysis, we showed that there are no works that use Google
Scholar for these purposes.
Based on this search engine, 21 online platforms were identified, on which the
largest number of articles on coronavirus topicswere published, ofwhich two samples
were identified as of December 15, 2020 (82 articles with the term “COVID-19” in
article titles and 63 articles with the term “Coronavirus” in article titles) articles with
over 1,000 citations inElsevier journals and over 500 times on other online platforms.
These articles have been categorized by authors, countries and institutions.
These samples of articleswere reduced to a single samplewith 125 articles that did
not overlap in two samples, on the basis of which a detailed analysis of the structures
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of international co-authorship with the identification of 31 countries, the authors of
which participated in international collaborations, was made. For this analysis, a
square symmetric matrix of international co-authorship was developed.
A content analysis of highly cited publications was carried out, revealing
overlapping topics, for which the multi-topic factor proposed by us was calculated.
In general, a quantitative analysis of the phenomenon of the coronavirus publica-
tion race showed a clear superiority in it of China, which inmany respects outstripped
its closest competitors—the USA and the UK.
Appendix 1. Platforms for Commercial Publishers
of Periodicals, Major Journals, Preprint Archives, Scientific
Networks and Servers of International and National Health
Organizations. Their Brief Description
1. Elsevier
Elsevier is a Netherlands-based information and analytics company specializing in
scientific, technical, andmedical content. Elsevier is a part of theRELXGroup,which
was known until 2015 as Reed Elsevier. It was founded as a small Dutch publisher
in 1880. Elsevier publishes more than 500,000 articles annually in 2,500 journals.
Its archives contain over 17 million documents and 40,000 e-books. Total yearly
downloads amount to more than 1 billion. [“2018 RELX Group Annual Report”
(PDF). RELX Company Reports. RELX. March 2019.]
2. Nature
“Nature is aweekly international journal publishing the finest peer-reviewed research
in all fields of science and technology on the basis of its originality, importance, inter-
disciplinary interest, timeliness, accessibility, elegance and surprising conclusions”
[https://www.nature.com/]. The first issue of Nature was published in November
1869. More than 88, 000 papers published Nature since 1900 are each represented
by doi.
3. Springer
Springer is a leading global scientific, technical and medical portfolio, providing
researchers in academia, scientific institutions and corporate R&D departments with
quality content through innovative information, products and services. It was founded
in 1842. Springer publishes more than 2,900 journals and 300,000 books [https://
www.springer.com/].
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4. Wiley Online Library
Wiley Online Library is a subscription-based library of John Wiley & Sons that
launched onAugust 7, 2010, replacingWiley InterScience [http://onlinelibrary.wiley.
com/]. It is a collection of online resources covering life, health, and physical sciences
as well as social science and the humanities. Wiley Online Library delivers access to
over 4 million articles from 1,600 journals, more than 22,000 books, and hundreds
of reference works, laboratory protocols, and databases from JohnWiley & Sons and
its imprints.
5. Oxford/Oxford Academic
Oxford University Press (OUP)
OxfordUniversity Press (OUP) is theworld’s leading university presswith thewidest
global presence.
The first book was printed in Oxford in 1478. In 1586 the University of Oxford’s
right to print books was recognized in a decree from the Star Chamber. Today OUP
has offices in 50 countries, and is the largest university press in the world. It now
publishes over 60 fully Open Access journals, alongside a number of Open Access
monographs, and offer an OpenAccess publishing option on almost all of its journals
[https://global.oup.com/academic/].
6. medrxiv
medRxiv … is a free online archive and distribution server for complete but
unpublished manuscripts (preprints) in the medical, clinical, and related health
sciences [https://www.medrxiv.org/content/about-medrxiv].Launched June2019.As
of January 17, 2021, it contains 1557 preprints.
7. Emerald -
Emerald Group Publishing/Emerald Publishing Limited
Emerald Publishing is one of the world’s leading digital first publishers, commis-
sioning, curating and showcasing research that canmake a real difference. Emerald—
Emerald Publishing Limited publishes social science research that tackles key soci-
etal challenges related to technology, business and people. It was founded in the
United Kingdom in 1967. Emerald Group Publishing has its headquarters in Bingley.
500 thousand researchers in over 130 countries, 30 million downloads per year, 109
million visitors worldwide. It has a portfolio of over 350 journals and 3,500 books”,
its content platform Emerald Insight is home to more than 255,000 current and
backfile articles across the fields of business, management, economics, engineering,
computing, technology and social science [http://www.emeraldinsight.com/].
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8. SAGE Publishing (formerly SAGE Publications)
SAGE Publishing, formerly SAGE Publications, is an independent publishing
company founded in 1965 in New York by Sara Miller McCune and now based
in Newbury Park, California. It publishes more than 1,000 journals, more than 800
books a year [https://uk.sagepub.com/en-gb/eur/home].
9. British Medical Journal (The BMJ)
The BMJ is a weekly peer-reviewed medical trade journal, published by the trade
union the British Medical Association (BMA). The BMJ has editorial freedom from
the BMA. It was founded in 1840. It is one of the world’s oldest general medical
journals. Originally called the British Medical Journal, the title was officially short-
ened to BMJ in 1988, and then changed to The BMJ in 2014. [https://www.bmj.com/
content/348/bmj.g4168.
10. arXiv
arXiv is a free distribution service and an open-access archive for 1,823,661 schol-
arly articles in the fields of physics, mathematics, computer science, quantitative
biology, quantitative finance, statistics, electrical engineering and systems science,
and economics. Materials on this site are not peer-reviewed by arXiv. Launched
August 14, 1991 [https://arxiv.org/].
11. The Journal of the American Medical Association (JAMA)
JAMA: The Journal of the AmericanMedical Association is a peer-reviewedmedical
journal published 48 times a year by the American Medical Association. It publishes
original research, reviews, and editorials covering all aspects of biomedicine. The
journal was established in 1883 with Nathan Smith Davis as the founding editor.
[https://www.ama-assn.org/about/ama-history/ama-history].
JAMA is the most widely circulated general medical journal in the world, with
more than 277,000 recipients of the print journal, more than 1.6 million recipients
of electronic tables of contents and alerts, and over 27 million annual visits to the
journal’s website. JAMA’s reach includes a growing social media presence (more
than 815,000 followers on Twitter and Facebook) and vast international news media
exposure [https://jamanetwork.com/journals/jama/pages/for-authors].
12. Cell
Cell is a peer-reviewed scientific journal publishing research papers across a broad
range of disciplineswithin the life sciences.Cellwas established in 1974byBenjamin
Lewin. It is publishedbimonthly byCell Press,which is an imprint ofElsevier [https://
www.cell.com/cell/home].
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13. National Acad Sciences PNAS
Proceedings of the National Academy of Sciences of the United States of America
(abbreviated PNAS or PNAS USA) is a peer-reviewed multidisciplinary scientific
journal. It is the official journal of the National Academy of Sciences. The journal
has been published since 1915. It publishes original research, scientific reviews,
commentaries, and letters [https://www.pnas.org/].
14. PLoS
PLOS One (stylized PLOS ONE, and formerly PLoS ONE) is a peer-reviewed
open access scientific journal. It has been published by the Public Library of
Science (PLOS) since 2006. In 2016 publication output in PLOS ONE was
22,054 research papers. [https://scholarlykitchen.sspnet.org/2017/01/05/plos-one-
output-drops-again-in-2016/]
15. BMC/BioMedCentral
BMC Medicine is a peer-reviewed electronic-only medical journal. It has been
published since 2003 by BioMed Central which is part of Springer Nature. It is
described as “the flagship medical journal of the BMC series. An open access, open
peer-reviewed general medical journal, BMC Medicine publishes outstanding and
influential research in all areas of clinical practice, translational medicine, medical
and health advances, public health, global health, policy, and general topics of interest
to the biomedical and sociomedical professional communities. BMC has an evolving
portfolio of some 300 peer-reviewed journals, sharing discoveries from research
communities in science, technology, engineering andmedicine [https://www.biomed
central.com/about].
16. The New England Journal of Medicine(NEJM), NEJM Group
The New England Journal of Medicine (NEJM) is recognized as the world’s leading
medical journal and website. Published continuously for over 200 years, NEJM
delivers high-quality, peer-reviewed research and interactive clinical content to physi-
cians, educators, researchers, and the global medical community. [https://www.nejm.
org/about-nejm/about-nejm]. The New England Journal of Medicine is a publication
ofNEJMGroup—Owned&Published by theMassachusettsMedical Society. Today,
NEJM is the most widely read, cited, and influential general medical periodical in
the world. More than 600,000 people from nearly every country read NEJM in print
and online each week. Each year, NEJM receives more than 16,000 research and
other submissions for consideration for publication. About 5% of original research
submissions achieve publication by NEJM; more than half originate from outside
the U.S [https://www.nejm.org/about-nejm/about-nejm].
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17. The World Health Organization (WHO)
TheWorld Health Organization (WHO) is a specialized agency of the UnitedNations
responsible for international public health. WHO began when our Constitution came
into force on 7 April 1948.WHO are nowmore than 7000 people frommore than 150
countries working in 150 country offices, in 6 regional offices and at our headquarters
in Geneva. [https://www.who.int/about].
18. The National Institutes of Health (NIH)
The National Institutes of Health (NIH), a part of the U.S. Department of Health and
Human Services, is the nation’smedical research agency—making important discov-
eries that improve health and save lives. The National Institutes of Health is made up
of 27 different components called Institutes and Centers. Each has its own specific
research agenda, often focusing on particular diseases or body systems. Headquarters
for the Office of the Director and the Institutes and Centers are located in Bethesda,
Maryland, USA.The NIH traces its roots to 1887, when a one-room laboratory was
created within the Marine Hospital Service (MHS), predecessor agency to the U.S.
Public Health Service (PHS). The MHS had been established in 1798 to provide for
the medical care of merchant seamen [https://www.nih.gov/].
19. ResearchGate
ResearchGate is a European commercial social networking site for scientists and
researchers. It was founded in 2008 by the physicians Dr. Ijad Madisch and Dr.
Sören Hofmayer along with computer specialist Horst Fickenscher. ResearchGate
has more than 19 million members and more than 130 million publications [https://
researchgate.net/press].
20. The National Bureau of Economic Research (NBER)
The National Bureau of Economic Research (NBER) is a private, nonpartisan orga-
nization that facilitates cutting-edge investigation and analysis of major economic
issues. It disseminates research findings to academics, public and private-sector
decision-makers, and the public by posting more than 1,200 working papers and
convening more than 120 scholarly conferences, each year. The National Bureau of
Economic Research (NBER) was founded in 1920, largely in response to heated
Progressive-era controversies over income distribution. The number of affiliated
researchers, just over 1,000 in 2008, was more than 1,500 in 2020 [https://www.
nber.org/].
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21. China CDC Weekly (CCDC Weekly)
China CDC Weekly (CCDC Weekly) serves as a platform for the China CDC.
CCDC Weekly publishes authoritative professional information on national popu-
lation health, disease and risk factor monitoring, investigation data and important
public health event investigation reports. China CDC will use the CCDC Weekly
to express views, countermeasures, and suggestions regarding Chinese and global
health issues and to report relevant research and surveillance data, reviews, and opin-
ions, etc. CCDCWeeklywill help guide public health and clinical practices to cement
the China CDC’s professional influence. Established in November 2019 [https://pub
lons.com/journal/672406/china-cdc-weekly/].
Appendix 2. Bibliographic Descriptions of Articles Ranked
by Google Scholar Citations as of 12/15/2020
1. HuangC,WangY, Li X et al. (2020) Clinical features of patients infectedwith
2019 novel coronavirus in Wuhan, China. The Lancet 395(10223):497−506.
https://doi.org/10.1016/S0140-6736(20)30183-5
2. Wang D, Hu B, Hu C et al. (2020) Clinical characteristics of 138 hospitalized
patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China.
JAMA 323(11):1061−1069. https://doi.org/10.1001/jama.2020.1585
3. Zhou F, Yu T, Du R et al. (2020) Clinical course and risk factors for mortality
of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort
study. The Lancet 395(10229):1054−1062. https://doi.org/10.1016/S0140-
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Appendix 3. Generalized Characteristics of Highly Cited
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1. China 1 29 16 19,786
2. China 1 14 1 11,247
3. China 1 19 9 10,824
4. China 1 14 9 9,967
5. China 1 2 1 8,012
6. China 1 29 4 7,893
7. China, Australia 2 35 12 5,458
8. China 1 21 3 5,034
9. China 1 17 7 3,842
10. UK 1 6 8 3,818
11. China, Australia 2 19 7 3,711
12. China 1 10 2 3,685
13. China 1 25 8 3,364
14. France 1 21 10 3,289
15. USA 1 6 3 2,873
16. China, USA, UK 3 4 8 2,870
17. USA 1 2 1 2,682
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18. China 1 7 5 2,552
19. China, USA 2 15 6 2,394
20. China 1 4 2 2,297
21. Taiwan 1 5 6 2,284
22. China 1 5 1 2,253
23. USA 1 2 4 2,220
24. China, USA 2 13 2 2,122
25. Italy 1 3 3 2,067
26. Netherlands 1 11 6 1,912
27. China, Singapore 2 9 5 1,907
28. China 1 8 3 1,823
29. UK 1 8 4 1,780
30. USA, Switzerland 2 10 2 1,753
31. China 1 6 2 1,727
32. China 1 18 5 1,682
33. China 1 21 4 1,668
34. UK, Netherlands 2 4 4 1,656
35. China 1 23 2 1,646
36. Italy 1 2 2 1,631
37. UK 1 33 3 1,618
38. Switzerland,
Greece
2 3 2 1,577
39. China 1 13 2 1,562
40. China 1 10 1 1,505
41. China 1 4 3 1,480
42. China 1 27 2 1,378
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7 12 14 1,276
47. China 1 14 8 1,267
48. USA 1 4 2 1,256
49. Singapore 1 7 2 1,244
50. China 1 13 4 1,226
51. India 1 1 1 1,211
52. UK 1 22 1 1,203
53. China 1 8 5 1,197
54. China, Canada 2 46 6 1,182
55. China 1 5 3 1,160
56. USA 1 7 3 1,139
57. China, Japan 2 3 3 1,117
58. USA, UK,
Australia, Sweden
4 25 24 1,107
59. China, Australia 2 7 5 1,094
60. UK 1 11 1 1,081
61. China, USA 2 11 10 1,049
62. USA 1 3 2 1,038
63. Italy 1 3 4 1,023
64. Singapore 1 5 3 1,013
65. China 1 48 8 979
66. China 1 51 12 971
67. UK 1 26 23 965
68. Belgium, France,
Italy
3 33 22 962
69. China, USA 2 16 8 948
70. China, USA,
Netherlands
3 11 5 935
71. USA, UK 2 2 3 921
72. China 1 37 24 894
73. China, Belgium 2 2 2 862
74. China 1 14 2 855
75. China 1 8 2 846
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76. China 1 3 2 829
77. Sweden 1 1 4 825





8 42 38 823
79. China 1 16 3 820
80. China, USA, UK,
Italy, Japan
5 8 9 803
81. USA 1 20 3 786
82. China 1 3 3 784
83. China 1 12 4 773
84. China 1 7 2 762
85. China 1 4 2 735
86. China 1 5 5 735
87. USA 1 15 8 733
88. China, USA 2 9 2 724
89. China 1 3 2 720
90. Italy 1 1 1 711
91. UK, Canada 2 2 4 707
92. USA 1 1 1 707
93. China 1 2 1 681
94. UK, Germany,
Italy
3 7 6 679
95. China 1 6 1 673
96. France 1 10 4 635
97. China, USA, Italy 3 10 7 633
98. UK 1 24 20 621
99. USA 1 3 2 616
100. China 1 7 3 612
101. Taiwan, USA 2 3 3 606
102. Italy 1 2 1 604





7 43 34 593
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105. China 1 5 1 591
106. China, USA 2 12 5 586
107. USA 1 2 4 583
108. China 1 12 4 570
109. USA 1 6 3 565
110. USA 1 6 2 565
111. USA 1 1 1 550
112. China 1 8 1 545
113. China 1 8 4 541
114. China 1 8 4 537
115. Brazil, Italy,
Paraguay
3 4 4 537
116. USA 1 14 4 535
117. Brazil, Spain 2 28 21 530
118. China 1 46 3 529
119. Germany, Greece,
Romania
3 28 9 518
120. China 1 6 3 515
121. China, USA 2 8 3 513
122. Australia 1 13 7 510
123. Spain 1 25 21 501
124. China 1 14 4 501
125. China 1 6 3 501
Appendix 4. Generalized Characteristics of Highly Cited
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